These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19038971)

  • 1. Phosphoinositide 3-kinase signalling in the vascular system.
    Morello F; Perino A; Hirsch E
    Cardiovasc Res; 2009 May; 82(2):261-71. PubMed ID: 19038971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide 3-kinase delta inhibitor as a novel therapeutic agent in asthma.
    Park SJ; Min KH; Lee YC
    Respirology; 2008 Nov; 13(6):764-71. PubMed ID: 18811876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?
    Rommel C; Camps M; Ji H
    Nat Rev Immunol; 2007 Mar; 7(3):191-201. PubMed ID: 17290298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.
    Hirano K
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):27-36. PubMed ID: 17095716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
    Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
    J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do phosphoinositide 3-kinases direct lymphocyte navigation?
    Ward SG
    Trends Immunol; 2004 Feb; 25(2):67-74. PubMed ID: 15102365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Barberis L; Hirsch E
    Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-selective PI3K inhibitors as novel therapeutics for the treatment of acute myocardial infarction.
    Doukas J; Wrasidlo W; Noronha G; Dneprovskaia E; Hood J; Soll R
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):204-6. PubMed ID: 17371238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of cellular differentiation and cellular function by phosphatidylinositol 3-kinase].
    Ptasznik A
    Postepy Hig Med Dosw; 2000; 54(5):609-18. PubMed ID: 11146889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K inhibitors in cardiovascular disease.
    Eisenreich A; Rauch U
    Cardiovasc Ther; 2011 Feb; 29(1):29-36. PubMed ID: 20626398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.
    Ito K; Caramori G; Adcock IM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):1-8. PubMed ID: 17021257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?
    Fougerat A; Gayral S; Malet N; Briand-Mesange F; Breton-Douillon M; Laffargue M
    Clin Sci (Lond); 2009 May; 116(11):791-804. PubMed ID: 19397491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
    Hirsch E; Lembo G; Montrucchio G; Rommel C; Costa C; Barberis L
    Thromb Haemost; 2006 Jan; 95(1):29-35. PubMed ID: 16543958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemistry and pathobiochemistry of signal transduction in cardiovascular cells].
    Walter U; Halbrügge M; Nolte C; Eigenthaler M; Lohman SM
    Verh Dtsch Ges Inn Med; 1991; 97():582-8. PubMed ID: 1808949
    [No Abstract]   [Full Text] [Related]  

  • 16. Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation.
    Parry RV; Riley JL; Ward SG
    Trends Immunol; 2007 Apr; 28(4):161-8. PubMed ID: 17336157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New responsibilities for the PI3K regulatory subunit p85 alpha.
    Okkenhaug K; Vanhaesebroeck B
    Sci STKE; 2001 Jan; 2001(65):pe1. PubMed ID: 11752634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of a selective beta-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat.
    Sturgeon SA; Jones C; Angus JA; Wright CE
    Eur J Pharmacol; 2008 Jun; 587(1-3):209-15. PubMed ID: 18455722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.
    Hawkins PT; Stephens LR
    Science; 2007 Oct; 318(5847):64-6. PubMed ID: 17916723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [corrected].
    Münzel T; Feil R; Mülsch A; Lohmann SM; Hofmann F; Walter U
    Circulation; 2003 Nov; 108(18):2172-83. PubMed ID: 14597579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.